Taken together, this model exhibiting α-synuclein over-expression localized to the cortices provides significant advantages over current transgenic models for evaluating the mechanisms observed in conditions of widespread cortical α-synuclein pathology, such as DLB. This evidence concerns the gene SNCA and Lewy body dementia.